CD38 Specific Chimeric Antigen Receptor KHYG-1 Natural Killer Cells: A Potential "Off the Shelf" Therapy for Multiple Myeloma

被引:0
|
作者
Stikvoort, Arwen [1 ]
Sarkar, Subhashis [2 ]
Poels, Renee [1 ]
van de Donk, Niels W. C. J. [1 ]
Zweegman, Sonja [1 ]
O'Dwyer, Michael E. [2 ]
Mutis, Tuna [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Dept Hematol, Amsterdam, Netherlands
[2] Natl Univ Ireland Galway, Sch Med, Biomed Sci, Galway, Ireland
关键词
D O I
10.1182/blood-2018-99-116403
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3261
引用
收藏
页数:3
相关论文
共 50 条
  • [21] FT576: A Novel Multiplexed Engineered Off-the-Shelf Natural Killer Cell Immunotherapy for the Dual-Targeting of CD38 and Bcma for the Treatment of Multiple Myeloma
    Bjordahl, Ryan
    Gaidarova, Svetlana
    Goodridge, Jode P.
    Mahmood, Sajid
    Bonello, Greg
    Robinson, Megan
    Ruller, Chelsea
    Pribadi, Mochtar
    Lee, Tom
    Abujarour, Ramzey
    Dinella, Jason
    Huffman, Janel
    Chu, Hui-yi
    Hopken, Uta
    Rehm, Armin
    Valamehr, Bahram
    BLOOD, 2019, 134
  • [22] Dual Chimeric Antigen Receptor T Cells Targeting CD38 and SLAMF7 with Independent Signaling Demonstrate Preclinical Efficacy and Safety in Multiple Myeloma
    Roders, Nathalie
    Nakid-Cordero, Cecilia
    Raineri, Fabio
    Fayon, Maxime
    Abecassis, Audrey
    Choisy, Caroline
    Nelson, Elisabeth
    Maillard, Claire
    Garrick, David
    Talbot, Alexis
    Fermand, Jean-Paul
    Arnulf, Bertrand
    Bories, Jean-Christophe
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (04) : 478 - 490
  • [23] T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells
    Mihara, K.
    Bhattacharyya, J.
    Kitanaka, A.
    Yanagihara, K.
    Kubo, T.
    Takei, Y.
    Asaoku, H.
    Takihara, Y.
    Kimura, A.
    LEUKEMIA, 2012, 26 (02) : 365 - 367
  • [24] T-Cell Immunotherapy with a Chimeric Receptor Against CD38 Is Effective in Eliminating Myeloma Cells
    Mihara, Keichiro
    Bhattacharyya, Joyeeta
    Kitanaka, Akira
    Ihara, Akihiro
    Sakai, Akira
    Kuroda, Yoshiaki
    Asaoku, Hideki
    Takihara, Yoshihiro
    Kimura, Akiro
    BLOOD, 2011, 118 (21) : 405 - 405
  • [25] T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells
    K Mihara
    J Bhattacharyya
    A Kitanaka
    K Yanagihara
    T Kubo
    Y Takei
    H Asaoku
    Y Takihara
    A Kimura
    Leukemia, 2012, 26 : 365 - 367
  • [26] Off-the-Shelf Prostate Stem Cell Antigen-Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer
    Teng, Kun-Yu
    Mansour, Anthony G.
    Zhu, Zheng
    Li, Zhiyao
    Tian, Lei
    Ma, Shoubao
    Xu, Bo
    Lu, Ting
    Chen, Hanyu
    Hou, David
    Zhang, Jianying
    Priceman, Saul J.
    Caligiuri, Michael A.
    Yu, Jianhua
    GASTROENTEROLOGY, 2022, 162 (04) : 1319 - 1333
  • [27] CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
    J Chu
    Y Deng
    D M Benson
    S He
    T Hughes
    J Zhang
    Y Peng
    H Mao
    L Yi
    K Ghoshal
    X He
    S M Devine
    X Zhang
    M A Caligiuri
    C C Hofmeister
    J Yu
    Leukemia, 2014, 28 : 917 - 927
  • [28] CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
    Chu, J.
    Deng, Y.
    Benson, D. M.
    He, S.
    Hughes, T.
    Zhang, J.
    Peng, Y.
    Mao, H.
    Yi, L.
    Ghoshal, K.
    He, X.
    Devine, S. M.
    Zhang, X.
    Caligiuri, M. A.
    Hofmeister, C. C.
    Yu, J.
    LEUKEMIA, 2014, 28 (04) : 917 - 927
  • [29] Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
    Garfall, Alfred L.
    Maus, Marcela V.
    Hwang, Wei-Ting
    Lacey, Simon F.
    Mahnke, Yolanda D.
    Melenhorst, J. Joseph
    Zheng, Zhaohui
    Vogl, Dan T.
    Cohen, Adam D.
    Weiss, Brendan M.
    Dengel, Karen
    Kerr, Naseem D. S.
    Bagg, Adam
    Levine, Bruce L.
    June, Carl H.
    Stadtmauer, Edward A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (11): : 1040 - 1047
  • [30] Chimeric Antigen Receptor (CAR) T Cells Specific for CD229: A Potentially Curative Approach for Multiple Myeloma
    Radhakrishnan, Sabarinath Venniyil
    Luetkens, Tim
    Yousef, Sara
    Bhardwaj, Neelam
    Steinbach, Mary Nicole
    Weidner, Janet
    Shorter, Christa
    Sborov, Douglas W.
    Atanackovic, Djordje
    BLOOD, 2017, 130